Skip to main content

Table 1 Patients’ characteristics

From: Multidisciplinary team meetings in treatment of spinal muscular atrophy adult patients: a real-life observatory for innovative treatments

 

SMA type 1 (n = 1)

SMA type 2 (n = 47)

SMA type 3 (n = 57)

SMA type 4 (n = 2)

Mean age in years (range)

44

33.3 (20–55)

37.4 (16–62)

48 (40–56)

Mean age at onset (y)

NA

NA

7.2

29.5

Mean SMN2 copy numbers

MD

2.9

3.3

4

Wheel chair bound (%)

1 (100)

47 (100)

31 (54)

0 (0)

Feeding tube

1

3

1

0

Spine fusion surgery (%)

1 (100)

41 (87.2)

18 (31.6)

0

Noninvasive ventilation/invasive ventilation

0/1

22/10

7/2

0/0

Median MFM32 (% total score)

NA

12 (0–40.6)

56.0 (14.6–83.0)

83 (MD)

Median 6MWT (meters) (range)

NA

NA

215 (0–450)

400

Median 10mWT (s) (range)

NA

NA

9.0 (0–36)

MD

Median RULM (range)

NA

7 (0–18)

17 (2–37)

MD

Median FVC (%) (range)

NA

25 (1.1–54)

93 (46–140)

MD

  1. MD missing data; MFM32 32-item motor function measure; NA not applicable; RULM revised upper limb module; SMA spinal muscular atrophy; 6MWT six-minute walking test; 10mWT ten-meter walking test